Sino Biopharmaceutical Ltd
(OTC: SBHMY)
|
2:55 PM UTC, 06/25/24 | |||
---|---|---|---|---|
Last: $6.69 | Change: -0.51 | %Change: -7.08% | Volume: 736 |
Open: | $ 6.69 | Volume: | 736 | |
---|---|---|---|---|
High: | $ 6.69 | Yield(%) | 1.54 | |
Low: | $ 6.69 | P/E Ratio (ttm): | 19.45 | |
Dividend ($): | 0.07 | Market Cap ($): | 6.34B | |
EPS ($) | 1.64 | Shares Out: | 916.86M |
% Price Change (last 4 weeks): | -4.94 |
---|---|
% Price Change (last 13 weeks): | -8.92 |
% Price Change (last 26 weeks): | -19.39 |
% Price Change (last 52 weeks): | -21.77 |
% Price Change (year to date): | -22.25 |
Return on Equity (%): | 6.23 |
---|---|
Return on Assets (%): | 2.94 |
Return on Invested Capital (%): | 14.70 |
Gross Profit Margin (%): | 80.95 |
---|---|
Net Profit Margin (%): | 7.22 |
Operating Profit Margin (%): | 22.01 |
|
|
50-day Moving Average: | $1.83 |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | 490 |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $9.41 |
52-wk low: | $6.68 |
Bid: | $n/a |
Ask: | $n/a |
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
|
Sino Biopharmaceutical Ltd
Office Tower 1 Harbour Road, Convention Plaza Unit 09, 41st Floor, Wanchai Hong Kong Phone: 852.2802.9886 Fax: n/a http://www.sinobiopharm.com |
Earnings (1year) ($): | 0.36 |
---|---|
Annual Dividend ($): | 0.11 |
Current P/E Ratio (ttm): | 19.45 |
Book Value ($): | 4.57 |
Cash Flow ($): | 0.51 |
Price/Earnings (x): | 19.45 |
---|---|
Price/Sales (x): | 2.23 |
Price/Book (x): | 1.94 |
Price/Cash Flow (x): | 8.82 |
Quick Ratio (x): | 0.96 |
---|---|
Current Ratio (x): | 1.05 |
LT Debt/Equity (x): | 4.50 |
Total Debt/Equity (x): | 41.73 |